default author photo

Thi Tuong Vy Le

Pasteur Institute - Pasteur Institute Ho Chi Minh City

167 Pasteur, Phường 8, Quận 3,

Ho Chi Minh

Vietnam

SCHOLARLY PAPERS

2

DOWNLOADS

359

TOTAL CITATIONS

1

Scholarly Papers (2)

1.

Safety and Immunogenicity of Nanocovax, a SARS-CoV-2 Recombinant Spike Protein Vaccine

Number of pages: 70 Posted: 14 Oct 2021
Nanogen Pharmaceutical Biotechnology JSC, Naval Medical University (SMMU), Pasteur Institute Ho Chi Minh City, Vietnam Military Medical University, Nanogen Pharmaceutical Biotechnology JSC, Vietnam Military Medical University, Pasteur Institute Ho Chi Minh City, Vietnam Military Medical University, Vietnam Military Medical University, Pasteur Institute - Department of Disease Control and Prevention, Pasteur Institute Ho Chi Minh City, Nanogen Pharmaceutical Biotechnology JSC, Nanogen Pharmaceutical Biotechnology JSC, Nanogen Pharmaceutical Biotechnology JSC, Nanogen Pharmaceutical Biotechnology JSC, Nanogen Pharmaceutical Biotechnology JSC, Nanogen Pharmaceutical Biotechnology JSC, Nanogen Pharmaceutical Biotechnology JSC, Vietnam Military Medical University, Vietnam Military Medical University, Vietnam Military Medical University, Vietnam Military Medical University, Vietnam Military Medical University, affiliation not provided to SSRN, affiliation not provided to SSRN, Vietnam Military Medical University, Vietnam Military Medical University, Vietnam Military Medical University, Vietnam Military Medical University, Vietnam Military Medical University, Vietnam Military Medical University, Vietnam Military Medical University, Vietnam Military Medical University, Vietnam Military Medical University, Vietnam Military Medical University, Vietnam Military Medical University, Vietnam Military Medical University, Vietnam Military Medical University, Vietnam Military Medical University, Pasteur Institute - Pasteur Institute Ho Chi Minh City, Pasteur Institute - Pasteur Institute Ho Chi Minh City, Pasteur Institute - Pasteur Institute Ho Chi Minh City, Pasteur Institute - Pasteur Institute Ho Chi Minh City, Pasteur Institute - Department of Disease Control and Prevention, Pasteur Institute - Pasteur Institute Ho Chi Minh City, Pasteur Institute - Pasteur Institute Ho Chi Minh City, Pasteur Institute - Pasteur Institute Ho Chi Minh City, Pasteur Institute - Pasteur Institute Ho Chi Minh City, Pasteur Institute - Pasteur Institute Ho Chi Minh City, Pasteur Institute - Pasteur Institute Ho Chi Minh City, Pasteur Institute - Pasteur Institute Ho Chi Minh City, Nanogen Pharmaceutical Biotechnology JSC, Nanogen Pharmaceutical Biotechnology JSC, Nanogen Pharmaceutical Biotechnology JSC, Nanogen Pharmaceutical Biotechnology JSC, Nanogen Pharmaceutical Biotechnology JSC, Nanogen Pharmaceutical Biotechnology JSC, Nanogen Pharmaceutical Biotechnology JSC, Nanogen Pharmaceutical Biotechnology JSC, Nanogen Pharmaceutical Biotechnology JSC and Nanogen Pharmaceutical Biotechnology JSC
Downloads 226 (339,185)

Abstract:

Loading...

SARS-CoV-2, Protein sub-unit vaccine, safety, immunogenicity, phase 1 and 2 clinical trial

2.

Efficacy, Safety, and Immunogenicity of an Inactivated, Adjuvanted Enterovirus 71 Vaccine EV71vac in Infants and Children: A Multi-Region, Double-Blinded, Randomised, Placebo-Controlled, Phase 3 Trial

Number of pages: 34 Posted: 04 Jan 2022
Pasteur Institute - Department of Disease Control and Prevention, Chang Gung University - Department of Pediatrics, Hsinchu MacKay Memorial Hospital - Department of Paediatrics, MacKay Children’s Hospital - Department of Paediatrics, Taichung Veterans General Hospital - Section of Infectious Disease, Pasteur Institute - Pasteur Institute Ho Chi Minh City, Centre for Disease Control of Tien Giang Province, Centre for Disease Control of Dong Thap Province, Cai Lay Regional General Hospital, Dong Thap Hospital, Children’s Hospital 1 - Department of Paediatrics, Pasteur Institute Ho Chi Minh City, Pasteur Institute - Pasteur Institute Ho Chi Minh City, Chang Gung University - Research Centre for Emerging Viral Infections, Linkou Chang Gung Memorial Hospital, Medigen Vaccine Biologics Corp., Medigen Vaccine Biologics Corp., Medigen Vaccine Biologics Corp., Medigen Vaccine Biologics Corp., Medigen Vaccine Biologics Corp. and National Taiwan University - Department of Paediatrics
Downloads 133 (547,695)
Citation 1

Abstract:

Loading...

Enterovirus 71 vaccine, efficacy, cross-protection, early infancy